StockData
Lifevantage Corp logo

Lifevantage Corp (LFVN) stock

LFVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 20/3044% below fair value
$4.78+0.01 (+0.21%)

Close on Nov 17, 2026Market cap $59.88MP/E 11.9Yield 3.87%

Lifevantage total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Lifevantage's total debt was $0 at Jun 30, 2020. For fiscal 2020 it was $0, down 100.0% from the year before. The highest annual figure on record is $29.77M in fiscal 2014.

Annual total debt

PeriodPeriod endValueChange
FY2020Jun 30, 2020$0-100.0%
FY2019Jun 30, 2019$1.45M-73.1%
FY2018Jun 30, 2018$5.41M-27.3%
FY2017Jun 30, 2017$7.44M-20.9%
FY2016Jun 30, 2016$9.41M-52.2%
FY2015Jun 30, 2015$19.67M-33.9%
FY2014Jun 30, 2014$29.77M–
FY2013Jun 30, 2013$0–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2020CQ2 2020Jun 30, 2020$0-100.0%
Q3 FY2020CQ1 2020Mar 31, 2020$0-100.0%
Q2 FY2020CQ4 2019Dec 31, 2019$484.00K-89.1%
Q1 FY2020CQ3 2019Sep 30, 2019$969.00K-80.3%
Q4 FY2019CQ2 2019Jun 30, 2019$1.45M-73.1%
Q3 FY2019CQ1 2019Mar 31, 2019$1.94M-67.5%
Q2 FY2019CQ4 2018Dec 31, 2018$4.43M-31.4%
Q1 FY2019CQ3 2018Sep 30, 2018$4.92M-29.2%
Q4 FY2018CQ2 2018Jun 30, 2018$5.41M-27.3%
Q3 FY2018CQ1 2018Mar 31, 2018$5.97M-24.8%
Q2 FY2018CQ4 2017Dec 31, 2017$6.46M-23.3%
Q1 FY2018CQ3 2017Sep 30, 2017$6.95M-22.1%
Q4 FY2017CQ2 2017Jun 30, 2017$7.44M–
Q3 FY2017CQ1 2017Mar 31, 2017$7.93M–
Q2 FY2017CQ4 2016Dec 31, 2016$8.42M–
Q1 FY2017CQ3 2016Sep 30, 2016$8.92M–

More Lifevantage figures

See a number that looks wrong?